Your browser doesn't support javascript.
loading
Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.
Lallas, A; Moscarella, E; Kittler, H; Longo, C; Thomas, L; Zalaudek, I; Kyrgidis, A; Manoli, S M; di Meo, N; Papageorgiou, C; Apalla, Z; Argenziano, G.
Afiliação
  • Lallas A; First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Moscarella E; DERMOMEDICA Dermatology Unit, Thessaloniki, Greece.
  • Kittler H; Dermatology Unit, University of Campania, Naples, Italy.
  • Longo C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Thomas L; Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
  • Zalaudek I; Azienda Unita Sanitaria Locale - IRCCS di Reggio Emilia, Centro Oncologico ad Alta Tecnologia Diagnostica-Dermatologia, Reggio Emilia, Italy.
  • Kyrgidis A; Department of Dermatology, Hospital Lyon Sud, France.
  • Manoli SM; Lyon 1 University, Lyon, France.
  • di Meo N; Lyons cancer research center INSERM U1052-CNRS UMR5286, France.
  • Papageorgiou C; Department of Dermatology, University of Trieste, Italy.
  • Apalla Z; Department of Oral & Maxillofacial Surgery, Aristotle University of Thessaloniki, Greece.
  • Argenziano G; First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Br J Dermatol ; 185(3): 675-677, 2021 09.
Article em En | MEDLINE | ID: mdl-33894006

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sarda Melanótica de Hutchinson / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sarda Melanótica de Hutchinson / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article